Testing effectiveness (Phase 2)Study completedNCT01859923
What this trial is testing
A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)
Who this might be right for
Multidrug Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 37